*NOTE: As requested by Drs. Marcelo and Umali, please visit http://telehealth.ph or email: This email address is being protected from spambots. You need JavaScript enabled to view it.

PHREB is inviting Biomedical researchers, policy makers and members of ethics committees, to attend the Ethics Pre-Forum on 24 August 2015, 1:00 – 5:00 PM, at Summit Hall C and D, Philippine International Convention Center (PICC), Pasay City. Please confirm attendance by returning the reply slip on or before August 07, 2015. Below is the programme of the event, for reference. Attendance to the Pre-forum is free of charge.

Participating in this pre-forum presents an excellent opportunity for you and your Society for professional development as well as engage other partners to make research and innovation benefit health, equity and development.

Should there be any concerns, contact the PHREB Secretariat at telephone number (02) 837 7537 or email at This email address is being protected from spambots. You need JavaScript enabled to view it..

Presented by PHREB Subcommittee on Standards and Accreditation Chair, Dr. Cecilia V. Tomas, during the Philippine Clinical Research Professionals' General Assembly last 4 March 2015 at UST Hospital Benavides Cancer Institute Auditorium, Manila

You may view or download the presentation by clicking the slide below

Click: 2014 PHREB Accreditation Policies and Procedures

 Please download the pdf file here.

Joint Memorandum Order 2012-001, which requires all health researches involving human subjects to undergo ethical review and clearance before implementation.

The issuance of this memorandum is expected to strengthen the advocacy for health research ethics in the country, and consequently ensure greater protection and promotion of the safety, dignity, and well-being of research participants.

"Clinical trials are conducted to evaluate the effectiveness and safety of new medications or medical devices. This is the bridge we need to take before introducing them for public use. Clinical trials should be carefully designed to ensure that no human is harmed or abused during the study period,” explained Dr. Suzette H. Lazo, Former Director of the FDA during the 6^th Philippine National Health Research System Week celebration.

Read more ...